LI AUTO-W(02015.HK) will spend HKD 104.35 million to repurchase 1.93 million shares on Jun 17, 2026 .
XIAOMI-W(01810.HK) will spend HKD 101.43 million to repurchase 4 million shares on Jun 17, 2026 .
NewTimeSpace News: Artini Holdings issued a profit warning on June 17, forecasting a net loss of approximately HK$9.6 million to HK$10 million for the financial year ending 31 March 2026.
NewTimeSpace News: Pine Technology Holdings disclosed in an announcement dated June 17 that Mr. Liu Haichao has resigned as Independent Non-executive Director as well as a member of the Audit Committee, Remuneration Committee and Nomination Committee. Mr. Song Hongdong has been appointed as Independent Non-executive Director to take over the membership of the aforesaid committees.
NewTimeSpace News: Peking University Resources issued a positive profit alert on June 17, forecasting a net profit of approximately RMB 1.4 billion to RMB 1.8 billion for the year ended 31 March 2026.
NewTimeSpace News: Beijing Enterprises Water Group announced on June 17 that the Company has completed the issuance of its third tranche of medium-term notes for 2026. The total issuance amount stands at RMB 1.2 billion with a five-year tenor and an annual coupon rate of 1.82%.
NewTimeSpace News: China Longyuan Power announced on June 17 that its 2025 annual equity distribution plan has been approved by the shareholders' meeting. Based on the total share capital of approximately 8.360 billion shares, the Company will distribute a pre-tax cash dividend of RMB 0.625 for every 10 shares held to all shareholders, with an aggregate final dividend payout of roughly RMB 522 million.
NewTimeSpace News: Shenwan Hongyuan announced on June 17 that the fourth tranche of publicly offered corporate bonds targeted at professional investors in 2026 issued by its subsidiary Shenwan Hongyuan Securities was listed on the Shenzhen Stock Exchange on the same day, with a total issuance size of RMB 3.6 billion.
NewTimeSpace News: New Focus announced on June 17 that with the approval of the independent board committee, Hord Capital Limited has been appointed as the independent financial adviser to advise the independent board committee and independent shareholders on the transaction of granting a loan to an associated subsidiary.
NewTimeSpace News: China Everbright Greentech announced on June 17 that the Company has entered separate framework agreements for hazardous waste disposal services spanning 2026 to 2028 with Everbright Environment China and Everbright Water, subsidiaries of its controlling shareholder Everbright Environment. The agreements have a term of approximately two and a half years, with an aggregated annual cap of around RMB 4 million per annum.
NewTimeSpace News: Muyuan Co., Ltd. announced on June 17 that the company has completed industrial and commercial registration modification. Its Chinese name has been changed from "Muyuan Foods Co., Ltd." to "Muyuan Foods Group Co., Ltd.".
NewTimeSpace News: CGII HLDGS announced on June 17 that the Company entered into a supplemental deed with the assignee and extended the completion date to June 17. The assignee has fully settled the consideration, and the loan assignment has been completed.
NewTimeSpace News: Guofu Hydrogen Energy announced on June 17 that The Stock Exchange of Hong Kong Limited (HKEX) has granted approval for its H-share full circulation scheme. A total of 18,416,758 domestic shares held by 22 shareholders of the Company will be converted into H-shares.
NewTimeSpace News: Wise Wealth Resources Investment announced on June 17 that Mr. Hao Xiaohui has been appointed as Executive Director and Co-Chairman with effect from June 17, 2026. Mr. Xu Shiping, former Chairman, is re-designated as Co-Chairman, while continuing to serve as Executive Director and Chairman of the Nomination Committee.
NewTimeSpace News: Fosun Pharma announced on June 17 that its controlled subsidiary Henlius has received approval from the National Medical Products Administration (NMPA) to conduct Phase I clinical trials for its self-developed HLX3902 Injection (STEAP1×CD3×CD28 trispecific antibody) in the treatment of metastatic castration-resistant prostate cancer and other advanced solid tumors.
NewTimeSpace News: Xunhe Group issued a profit warning on June 17, forecasting a net loss of approximately HK$13 million to HK$16 million for the year ended March 31, 2026, representing a substantial widening from the previous year’s net loss of around HK$5.7 million.
